Skip to main content
. 2003 Oct 20;2003(4):CD001332. doi: 10.1002/14651858.CD001332

Wade 2003.

Methods Crossover study with 2 week blocks, without intervening washout periods
Participants 24 patients with intractable neurogenic symptoms, 18 with MS
Interventions THC v. CBD v. 1:1 mixture of THC:CBD v. placebo
Outcomes daily patient visual analogue scales, Ashworth score, numerical investigator rating of symptoms
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? High risk C ‐ Inadequate